Erectile dysfunction (ED) arises from vascular insufficiency, endothelial dysfunction, smooth-muscle pathology, or neurogenic impairment — often clustering with metabolic syndrome, atherosclerosis, and diabetes.
Erectile dysfunction (ED) arises from vascular insufficiency, endothelial dysfunction, smooth-muscle pathology, or neurogenic impairment — often clustering with metabolic syndrome, atherosclerosis, and diabetes. Stem-cell investigations focus on whether placental mesenchymal stem cells and exosome preparations can regenerate penile vasculature, restore endothelial nitric-oxide-dependent relaxation, and repair cavernous smooth-muscle tissue. With 35 registered trials and 5 currently recruiting, the biological rationale targets restoration of penile erectile mechanics through vascular and tissue regeneration. Early clinical data suggest potential for improving erectile function, increasing rigidity and tumescence duration, and potentially reducing pharmacological dependence on phosphodiesterase-5 inhibitors when stem-cell therapy complements standard medical management.
| 指示性成本 · 保加利亚 (EU) | €3,000–€8,000 |
|---|---|
| 全球市场成本范围 | €20,100–€23,400 (bookinghealth.com) |
| 研究的主要细胞类型 | MSCs from Amniotic Membrane, Exosomes |
| 批准状态 | 研究性 |
| 注册的临床试验 (ClinicalTrials.gov) | 35 · 5 recruiting now |
For the clinic's own description, see how Stem Plus describes its Erectile Dysfunction programme ↗.
Erectile dysfunction trials remain relatively small and heterogeneous in outcome measurement. Five actively recruiting studies suggest ongoing clinical interest and demand. Published data report improvements in erectile function scores (International Index of Erectile Function or similar validated scales) following MSC or exosome infusion, with approximately 40–60% of treated patients showing measurable functional improvement within 3–6 months. Some trials documented improved response to phosphodiesterase-5 inhibitors in previously non-responsive patients. Duplex ultrasound studies showed improved cavernous artery flow in responsive cohorts. However, many studies lack sham-procedure controls; placebo effect is substantial in ED trials. Durability and long-term function beyond 12–24 months remain inadequately documented. Mechanism studies provide plausible biological rationale but lack definitive in-vivo confirmation.
Depending on assessment, a Erectile Dysfunction protocol may draw on:
Erectile dysfunction stem-cell treatment costs typically range €3,500–7,000 per cycle, reflecting local penile injection or systemic infusion protocols. Exosome-based formulations, when offered, may cost similarly or slightly higher due to manufacturing. Single-infusion protocols are standard; repeat treatments are proposed at 6–12 month intervals if benefit plateaus. Placental MSC sourcing and preparation costs are modest relative to some other conditions. European programmes (Spain, Germany, Italy) typically charge €4,000–6,000; private boutique andrology clinics may exceed €7,000. Ancillary costs — baseline erectile function assessment, penile Duplex ultrasound — add £500–1,500 but are essential for outcome measurement.
Indicative EU treatment cost is €3,000–€8,000 versus roughly €15,000–35,000 in the US or Germany. Build your real all-in total with the cost calculator, see the Erectile Dysfunction cost-by-country breakdown, or compare the best countries for Erectile Dysfunction →
Before booking, check safety & regulation, the recovery climate, 您是否可能是候选人, and which cell type fits Erectile Dysfunction.
We link primary regulators, registries and peer-reviewed research so you can verify everything yourself — plus the treating clinic's own materials.
Useful tools & guides: 我是候选人吗？ · 哪种细胞类型？ · Types of clinics & best countries · 成本计算器
由 StemCellAtlas 的编辑团队进行医学审查，与Dr Dmytro Stoyanov (Urologist · 31+ yrs clinical practice) 合作诊所 Stem Plus（索菲亚）的，根据 ISSCR、FDA 和 EMA 指南。 Educational information, not medical advice; figures indicative.
位于欧盟核心的 GMP 认证再生医学诊所——费用 3,000–8,000 欧元起，仅为美国或德国价格的一小部分。为来自 50 多个国家的国际患者提供个性化方案。
免费医疗评估